investorscraft@gmail.com

Intrinsic Value of Angion Biomedica Corp. (ANGN)

Previous Close$0.00
Intrinsic Value
Upside potential
Previous Close
$0.00
* Our model cannot be used “out of the box” for the valuation of this stock. You can still do your own valuation by changing the valuation input parameters.

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2022-12-31 and quarterly data as of 2023-06-30.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2023202420252026202720282029203020312032203320342035203620372038203920402041204220432044204520462047

INCOME STATEMENT

Revenue growth rate, %-91.9NaN
Revenue, $2NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m42NaN
Operating income, $m-40NaN
EBITDA, $m-39NaN
Interest expense (income), $mNaN
Earnings before tax, $m-56NaN
Tax expense, $m-17NaN
Net income, $m-39NaN

BALANCE SHEET

Cash and short-term investments, $m50NaN
Total assets, $m53NaN
Adjusted assets (=assets-cash), $m2NaN
Average production assets, $m1110NaN
Working capital, $m45NaN
Total debt, $m1NaN
Total liabilities, $m9NaN
Total equity, $m44NaN
Debt-to-equity ratio0.028NaN
Adjusted equity ratio-2.455NaN

CASH FLOW

Net income, $m-39NaN
Depreciation, amort., depletion, $m1NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m-38NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m0NaN
Free cash flow, $m-38NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m45
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount